Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank

Publication ,  Conference
Guggenheim, DS; Kurtzberg, J; Shaz, B
Published in: Stem Cells Translational Medicine
September 6, 2022

Duke Scholars

Published In

Stem Cells Translational Medicine

DOI

EISSN

2157-6580

ISSN

2157-6564

Publication Date

September 6, 2022

Volume

11

Issue

Supplement_1

Start / End Page

S32 / S32

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • 4003 Biomedical engineering
  • 3206 Medical biotechnology
  • 1103 Clinical Sciences
  • 1004 Medical Biotechnology
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guggenheim, D. S., Kurtzberg, J., & Shaz, B. (2022). Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank. In Stem Cells Translational Medicine (Vol. 11, pp. S32–S32). Oxford University Press (OUP). https://doi.org/10.1093/stcltm/szac057.027
Guggenheim, Dana S., Joanne Kurtzberg, and Beth Shaz. “Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank.” In Stem Cells Translational Medicine, 11:S32–S32. Oxford University Press (OUP), 2022. https://doi.org/10.1093/stcltm/szac057.027.
Guggenheim DS, Kurtzberg J, Shaz B. Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank. In: Stem Cells Translational Medicine. Oxford University Press (OUP); 2022. p. S32–S32.
Guggenheim, Dana S., et al. “Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank.” Stem Cells Translational Medicine, vol. 11, no. Supplement_1, Oxford University Press (OUP), 2022, pp. S32–S32. Crossref, doi:10.1093/stcltm/szac057.027.
Guggenheim DS, Kurtzberg J, Shaz B. Abstract 27 Limitations of Current Human Cell, Tissue, and Cellular-based Product Donor Eligibility Guidance: Analyzing the Impact on a Large Public Cord Blood Bank. Stem Cells Translational Medicine. Oxford University Press (OUP); 2022. p. S32–S32.

Published In

Stem Cells Translational Medicine

DOI

EISSN

2157-6580

ISSN

2157-6564

Publication Date

September 6, 2022

Volume

11

Issue

Supplement_1

Start / End Page

S32 / S32

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • 4003 Biomedical engineering
  • 3206 Medical biotechnology
  • 1103 Clinical Sciences
  • 1004 Medical Biotechnology
  • 0601 Biochemistry and Cell Biology